- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.30 Å
- Oligo State
- homo-trimer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.6: 2 residues within 4Å:- Chain A: A.706, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.18: 3 residues within 4Å:- Chain B: A.706, E.1072, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.29: 2 residues within 4Å:- Chain C: E.1072, N.1074
No protein-ligand interaction detected (PLIP)- 11 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.1098, T.1100, D.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 1 residues within 4Å:- Chain A: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.9: 3 residues within 4Å:- Chain A: S.112, E.132, N.165
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.10: 3 residues within 4Å:- Chain A: G.339, N.343, V.367
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.19: 4 residues within 4Å:- Chain B: N.1098, T.1100, D.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.20: 1 residues within 4Å:- Chain B: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.21: 3 residues within 4Å:- Chain B: F.338, G.339, N.343
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.30: 4 residues within 4Å:- Chain C: N.1098, T.1100, D.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.31: 1 residues within 4Å:- Chain C: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.32: 5 residues within 4Å:- Chain B: A.352, I.468
- Chain C: E.132, N.164, N.165
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.33: 5 residues within 4Å:- Chain B: N.487, Y.489
- Chain C: F.342, N.343, F.374
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.487, B:Y.489
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.34: 1 residues within 4Å:- Chain A: N.61
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: N.122, T.124, N.125
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain A: K.147, N.149
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: N.234, T.236
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.282
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain A: N.709
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain A: Y.1155, N.1158
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.61
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.149
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain B: G.232, N.234
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.331
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: N.603, T.604
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain B: N.709, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain B: N.1158
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.61
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: K.147, N.149
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: N.603, T.604
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: N.709, N.710
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1158
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, J. et al., Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (2021)
- Release Date
- 2021-11-03
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.30 Å
- Oligo State
- homo-trimer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 11 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, J. et al., Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (2021)
- Release Date
- 2021-11-03
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C